Effects of Exercise Training on the Renin-Angiotensin System in the Kidneys of Dahl Salt-Sensitive Rats. 2022

Akihiro Sakuyama, and Yoshiko Ogawa, and Lusi Xu, and Miwa Komatsu, and Takahiro Miura, and Asako Namai-Takahashi, and Masahiro Kohzuki, and Osamu Ito

Exercise training (Ex) has antihypertensive and renal protective effects; however, the precise mechanisms remain unclear. The renal renin-angiotensin system (RAS) plays a vital role in renal function and pathology. Therefore, we investigated the effects of Ex on the renal RAS components in Dahl salt-sensitive (Dahl-S) rats. Male Dahl-S rats were divided into four groups: normal salt diet + sedentary, normal salt diet + Ex, high-salt diet (HS, 8% NaCl) + sedentary, and HS + Ex. Treadmill running was performed for 8 wk in the Ex groups. Ex attenuated the HS-induced renal dysfunction and glomerular injury without causing blood pressure alterations. HS increased urinary excretion of both total and intact angiotensinogen. Ex decreased the HS-induced increased urinary excretion of total angiotensinogen. However, it did not change the HS-induced urinary excretion of intact angiotensinogen, indicating reduced intact angiotensinogen cleaving. Ex restored the HS-induced increased angiotensinogen and angiotensin II type 1 receptor expressions in the outer medulla and the HS-induced increased angiotensin-converting enzyme expression in the cortex. Ex restored the HS-induced decreased renin expression in the cortex and outer medulla, and the HS-induced decreased angiotensin-converting enzyme 2, angiotensin II type 2 receptor, and Mas receptor expressions in the outer medulla. Ex attenuates HS-induced renal dysfunction, glomerular injury, and renal RAS dysregulation in Dahl-S rats.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D010805 Physical Conditioning, Animal Diet modification and physical exercise to improve the ability of animals to perform physical activities. Animal Physical Conditioning,Animal Physical Conditionings,Conditioning, Animal Physical,Conditionings, Animal Physical,Physical Conditionings, Animal
D012084 Renin-Angiotensin System A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM. Renin-Angiotensin-Aldosterone System,Renin Angiotensin Aldosterone System,Renin Angiotensin System,System, Renin-Angiotensin,System, Renin-Angiotensin-Aldosterone
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D000808 Angiotensinogen An alpha-globulin of about 453 amino acids, depending on the species. It is produced by the liver in response to lowered blood pressure and secreted into blood circulation. Angiotensinogen is the inactive precursor of the ANGIOTENSINS produced in the body by successive enzyme cleavages. Cleavage of angiotensinogen by RENIN yields the decapeptide ANGIOTENSIN I. Further cleavage of angiotensin I (by ANGIOTENSIN CONVERTING ENZYME) yields the potent vasoconstrictor octapeptide ANGIOTENSIN II; and then, via other enzymes, other angiotensins also involved in the hemodynamic-regulating RENIN-ANGIOTENSIN SYSTEM. Hypertensinogen,Renin-Substrate,SERPINA8,Proangiotensin,Renin Substrate Tetradecapeptide,Serpin A8,Renin Substrate,Tetradecapeptide, Renin Substrate
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D020303 Rats, Inbred Dahl Inbred rats derived from Sprague-Dawley rats and used for the study of salt-dependent hypertension. Salt-sensitive and salt-resistant strains have been selectively bred to show the opposite genetically determined blood pressure responses to excess sodium chloride ingestion. Dahl Hypertensive Rats,Dahl Rat,Dahl Salt-Resistant Rats,Dahl Salt-Sensitive Rat,Dahl Salt-Sensitive Rats,Dahl Rats,Dahl Rats, Inbred,Dahl Salt Resistant Rats,Dahl Salt Sensitive Rat,Dahl Salt Sensitive Rats,Hypertensive Rats, Dahl,Inbred Dahl Rats,Rat, Dahl,Rat, Dahl Salt-Sensitive,Rats, Dahl,Rats, Dahl Hypertensive,Rats, Dahl Salt-Resistant,Rats, Dahl Salt-Sensitive,Salt-Resistant Rats, Dahl,Salt-Sensitive Rat, Dahl,Salt-Sensitive Rats, Dahl

Related Publications

Akihiro Sakuyama, and Yoshiko Ogawa, and Lusi Xu, and Miwa Komatsu, and Takahiro Miura, and Asako Namai-Takahashi, and Masahiro Kohzuki, and Osamu Ito
January 2001, Journal of hypertension,
Akihiro Sakuyama, and Yoshiko Ogawa, and Lusi Xu, and Miwa Komatsu, and Takahiro Miura, and Asako Namai-Takahashi, and Masahiro Kohzuki, and Osamu Ito
May 1997, American journal of hypertension,
Akihiro Sakuyama, and Yoshiko Ogawa, and Lusi Xu, and Miwa Komatsu, and Takahiro Miura, and Asako Namai-Takahashi, and Masahiro Kohzuki, and Osamu Ito
November 1999, Clinical and experimental pharmacology & physiology,
Akihiro Sakuyama, and Yoshiko Ogawa, and Lusi Xu, and Miwa Komatsu, and Takahiro Miura, and Asako Namai-Takahashi, and Masahiro Kohzuki, and Osamu Ito
September 1998, Hypertension research : official journal of the Japanese Society of Hypertension,
Akihiro Sakuyama, and Yoshiko Ogawa, and Lusi Xu, and Miwa Komatsu, and Takahiro Miura, and Asako Namai-Takahashi, and Masahiro Kohzuki, and Osamu Ito
June 1997, Genes and function,
Akihiro Sakuyama, and Yoshiko Ogawa, and Lusi Xu, and Miwa Komatsu, and Takahiro Miura, and Asako Namai-Takahashi, and Masahiro Kohzuki, and Osamu Ito
January 1999, Journal of hypertension,
Akihiro Sakuyama, and Yoshiko Ogawa, and Lusi Xu, and Miwa Komatsu, and Takahiro Miura, and Asako Namai-Takahashi, and Masahiro Kohzuki, and Osamu Ito
April 2009, Journal of hypertension,
Akihiro Sakuyama, and Yoshiko Ogawa, and Lusi Xu, and Miwa Komatsu, and Takahiro Miura, and Asako Namai-Takahashi, and Masahiro Kohzuki, and Osamu Ito
October 1993, Journal of hypertension,
Akihiro Sakuyama, and Yoshiko Ogawa, and Lusi Xu, and Miwa Komatsu, and Takahiro Miura, and Asako Namai-Takahashi, and Masahiro Kohzuki, and Osamu Ito
January 1998, American journal of hypertension,
Akihiro Sakuyama, and Yoshiko Ogawa, and Lusi Xu, and Miwa Komatsu, and Takahiro Miura, and Asako Namai-Takahashi, and Masahiro Kohzuki, and Osamu Ito
December 1986, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!